CeQur said today that it acquired a wearable, on-demand insulin delivery system from Johnson & Johnson‘s (NYSE:JNJ) Calibra Medical for an undisclosed amount. The Calibra device is designed to dose rapid-acting, mealtime insulin for people with Type II diabetes. In a 278-person study, use of the Calibra device resulted in higher ease-of-use and patient satisfaction […]
Calibra Medical Inc.
Ethicon study reports bariatric surgery as effective treatment for Asian Indian type II patients | American Diabetes Assn. 2016 Scientific Sessions
Ethicon study reports bariatric surgery as effective treatment for Asian Indian type II patients Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon said it presented data from a study supporting bariatric surgery as a better treatment option than medical therapy and lifestyle management for obese Asian Indian patients with inadequately controlled type 2 diabetes. Data came from […]
Diabetes: J&J units join Joslin tech transfer project
Health care seed investment sees sharp Q1 drop | Funding roundup
The share of healthcare investment dollars going to early stage deals dropped sharply in the first quarter of this year to its lowest level in five quarters.
In the first quarter of 2011, just 1 percent of healthcare venture deals involved seed-stage companies, according to a report from New York research firm CB Insights.
That compares with 6 percent of the deals the prior quarter and 3 percent in last year’s first quarter.
